Last update 21 Nov 2024

LanQin Oral Liquid

Overview

Basic Info

Drug Type
Herbal medicine
Synonyms-
Target-
Mechanism-
Therapeutic Areas
Infectious DiseasesMouth and Tooth DiseasesOtorhinolaryngologic Diseases+ [1]
Active Indication
PharyngitisAcute pharyngitis
Inactive Indication-
Originator Organization
Jiangsu Yangtze River Pharmaceutical Group Co., Ltd.Jiangsu Yangtze River Pharmaceutical Group Co., Ltd.
Active Organization
Yangzijiang Pharmaceutical Group Jiangsu Longfengtang Traditional Chinese Medicine Co., Ltd.Yangzijiang Pharmaceutical Group Jiangsu Longfengtang Traditional Chinese Medicine Co., Ltd.Jiangsu Yangtze River Pharmaceutical Group Co., Ltd.Jiangsu Yangtze River Pharmaceutical Group Co., Ltd.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
CN (27 Apr 2020),
Pharyngitis
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with LanQin Oral Liquid
CTR20240843 / RecruitingPhase 2
评价蓝芩口服液治疗小儿急性咽炎（肺胃实热证）的有效性和安全性的多中心、随机、双盲、安慰剂对照Ⅱ期临床试验
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase II clinical trial to evaluate the efficacy and safety of Lanqin oral solution in the treatment of acute pharyngitis (lung and stomach heat syndrome) in children
100 Clinical Results associated with LanQin Oral Liquid
Login to view more data
100 Translational Medicine associated with LanQin Oral Liquid
Login to view more data
100 Patents (Medical) associated with LanQin Oral Liquid
Login to view more data
100 Deals associated with LanQin Oral Liquid
Login to view more data

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Pharyngitis
CN
Yangzijiang Pharmaceutical Group Jiangsu Longfengtang Traditional Chinese Medicine Co., Ltd.Yangzijiang Pharmaceutical Group Jiangsu Longfengtang Traditional Chinese Medicine Co., Ltd.
27 Apr 2020
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute pharyngitisPhase 2
CN
Jiangsu Yangtze River Pharmaceutical Group Co., Ltd.Jiangsu Yangtze River Pharmaceutical Group Co., Ltd.
09 Apr 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free